BG104915A - Azabicyclic 5hti receptor ligands - Google Patents

Azabicyclic 5hti receptor ligands

Info

Publication number: BG104915A
Authority: BG; Bulgaria
Prior art keywords: azabicyclic; receptor ligands; 5hti; 5hti receptor; compounds
Prior art date: 1998-04-09

Application number

BG104915A

Other languages

Bulgarian (bg)

English (en)

Inventor

Gene BRIGHT

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-09

Filing date

2000-11-07

Publication date

2001-07-31

2000-11-07 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2001-07-31 Publication of BG104915A publication Critical patent/BG104915A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Addiction (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Psychology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Luminescent Compositions (AREA)

BG104915A 1998-04-09 2000-11-07 Azabicyclic 5hti receptor ligands BG104915A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8123798P	1998-04-09	1998-04-09
PCT/IB1999/000457 WO1999052907A1 (fr)	1998-04-09	1999-03-18	Ligands azabicycliques du recepteur 5ht1

Publications (1)

Publication Number	Publication Date
BG104915A true BG104915A (en)	2001-07-31

Family

ID=22162936

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104915A BG104915A (en)	1998-04-09	2000-11-07	Azabicyclic 5hti receptor ligands

Country Status (40)

Country	Link
US (2)	US6525048B1 (fr)
EP (1)	EP1070065B1 (fr)
JP (1)	JP3496759B2 (fr)
KR (1)	KR100378931B1 (fr)
CN (1)	CN1117092C (fr)
AP (1)	AP1175A (fr)
AR (1)	AR015751A1 (fr)
AT (1)	ATE248838T1 (fr)
AU (1)	AU749254B2 (fr)
BG (1)	BG104915A (fr)
BR (1)	BR9909522A (fr)
CA (1)	CA2327782A1 (fr)
CO (1)	CO5080727A1 (fr)
CZ (1)	CZ20003684A3 (fr)
DE (1)	DE69910997T2 (fr)
DK (1)	DK1070065T3 (fr)
DZ (1)	DZ2756A1 (fr)
EA (1)	EA003400B1 (fr)
ES (1)	ES2204154T3 (fr)
HR (1)	HRP20000653A2 (fr)
HU (1)	HUP0102400A3 (fr)
ID (1)	ID26086A (fr)
IL (1)	IL138629A0 (fr)
IS (1)	IS5641A (fr)
MA (1)	MA26619A1 (fr)
MY (1)	MY133390A (fr)
NO (1)	NO20005004L (fr)
NZ (1)	NZ507010A (fr)
OA (1)	OA11496A (fr)
PA (1)	PA8469101A1 (fr)
PE (1)	PE20000413A1 (fr)
PL (1)	PL343408A1 (fr)
PT (1)	PT1070065E (fr)
SK (1)	SK14782000A3 (fr)
TN (1)	TNSN99056A1 (fr)
TR (1)	TR200002932T2 (fr)
TW (1)	TW555758B (fr)
WO (1)	WO1999052907A1 (fr)
YU (1)	YU59400A (fr)
ZA (1)	ZA992596B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6231833B1 (en) *	1999-08-05	2001-05-15	Pfizer Inc	2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
UA62015C2 (en) *	1998-12-28	2003-12-15	Pfizer Prod Inc	Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
DE60026146T2 (de) *	1999-09-03	2006-08-17	Apbi Holdings, Llc	Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
GB2362826A (en) *	2000-06-02	2001-12-05	Lilly Co Eli	A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US6855729B2 (en) *	2001-02-20	2005-02-15	Timothy G. Dinan	Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
EP1608648B1 (fr) *	2003-03-12	2012-07-18	Pfizer Products Inc.	Derives azabicycliques de pyridyloxymethyl et de benzisoxazole
BRPI0507250A (pt) *	2004-01-29	2007-06-26	Pfizer Prod Inc	combinações para tratar desordens do snc
JP4559749B2 (ja) *	2004-02-16	2010-10-13	あすか製薬株式会社	ピペラジニルピリジン誘導体
AR049478A1 (es)	2004-03-25	2006-08-09	Solvay Pharm Bv	Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
AR048112A1 (es)	2004-03-25	2006-03-29	Solvay Pharm Bv	Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
WO2006000914A1 (fr) *	2004-06-22	2006-01-05	Pfizer Products Inc.	Antagonistes des recepteurs d'histamine-3 diazabicycliques
JP5173190B2 (ja)	2004-08-25	2013-03-27	武田薬品工業株式会社	腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
EP1791540A2 (fr) *	2004-09-10	2007-06-06	Pfizer Products Incorporated	Methodes destinees a traiter des troubles cognitifs au moyen de derives azabicycliques de pyridyloxymethyle et de benzisoxazole
RU2417082C2 (ru) *	2009-07-14	2011-04-27	Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран)	Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
WO2020087031A1 (fr)	2018-10-26	2020-04-30	The Research Foundation For The State University Of New York	Combinaison d'un inhibiteur de réabsorption spécifique de la sérotonine et d'un agoniste partiel du récepteur de la sérotonine 1a pour réduire la dyskinésie induite par l-dopa
WO2020183011A1 (fr)	2019-03-14	2020-09-17	Institut Curie	Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5106849A (en) *	1988-05-24	1992-04-21	American Home Products Corporation	Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders
WO1990008148A1 (fr) *	1989-01-23	1990-07-26	Pfizer Inc.	Agents anxiolytiques bis-aza-bicycliques
US5157034A (en) *	1991-02-27	1992-10-20	Pfizer Inc.	Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
DK0607163T3 (da) *	1991-09-25	1997-03-17	Pfizer	Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner
US5262428A (en) *	1992-03-13	1993-11-16	Wake Forest University	Biologically active tropane derivatives
ATE185565T1 (de) *	1992-06-16	1999-10-15	Pfizer	Verfahren und zwischenprodukte zur herstellung von bis-aza-bicyclischen anxiolytica
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
US5731307A (en) *	1994-09-30	1998-03-24	Pfizer, Inc.	Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US5614523A (en) *	1995-01-17	1997-03-25	Eli Lilly And Company	Compounds having effects on serotonin-related systems

1999
- 1999-03-17 PA PA19998469101A patent/PA8469101A1/es unknown
- 1999-03-18 CN CN99807195A patent/CN1117092C/zh not_active Expired - Fee Related
- 1999-03-18 TR TR2000/02932T patent/TR200002932T2/xx unknown
- 1999-03-18 NZ NZ507010A patent/NZ507010A/en unknown
- 1999-03-18 ID IDW20002017A patent/ID26086A/id unknown
- 1999-03-18 DE DE69910997T patent/DE69910997T2/de not_active Expired - Fee Related
- 1999-03-18 SK SK1478-2000A patent/SK14782000A3/sk unknown
- 1999-03-18 JP JP2000543464A patent/JP3496759B2/ja not_active Expired - Fee Related
- 1999-03-18 HU HU0102400A patent/HUP0102400A3/hu unknown
- 1999-03-18 CA CA002327782A patent/CA2327782A1/fr not_active Abandoned
- 1999-03-18 AU AU32687/99A patent/AU749254B2/en not_active Ceased
- 1999-03-18 PL PL99343408A patent/PL343408A1/xx not_active Application Discontinuation
- 1999-03-18 EA EA200000910A patent/EA003400B1/ru not_active IP Right Cessation
- 1999-03-18 IL IL13862999A patent/IL138629A0/xx unknown
- 1999-03-18 YU YU59400A patent/YU59400A/sh unknown
- 1999-03-18 DK DK99945686T patent/DK1070065T3/da active
- 1999-03-18 CZ CZ20003684A patent/CZ20003684A3/cs unknown
- 1999-03-18 ES ES99945686T patent/ES2204154T3/es not_active Expired - Lifetime
- 1999-03-18 WO PCT/IB1999/000457 patent/WO1999052907A1/fr not_active Ceased
- 1999-03-18 HR HR20000653A patent/HRP20000653A2/hr not_active Application Discontinuation
- 1999-03-18 AT AT99945686T patent/ATE248838T1/de not_active IP Right Cessation
- 1999-03-18 EP EP99945686A patent/EP1070065B1/fr not_active Expired - Lifetime
- 1999-03-18 KR KR10-2000-7011167A patent/KR100378931B1/ko not_active Expired - Fee Related
- 1999-03-18 BR BR9909522-0A patent/BR9909522A/pt not_active Application Discontinuation
- 1999-03-18 PT PT99945686T patent/PT1070065E/pt unknown
- 1999-03-18 US US09/403,892 patent/US6525048B1/en not_active Expired - Fee Related
- 1999-04-02 TW TW088105301A patent/TW555758B/zh not_active IP Right Cessation
- 1999-04-05 PE PE1999000270A patent/PE20000413A1/es not_active Application Discontinuation
- 1999-04-07 TN TNTNSN99056A patent/TNSN99056A1/fr unknown
- 1999-04-07 AR ARP990101572A patent/AR015751A1/es unknown
- 1999-04-07 DZ DZ990057A patent/DZ2756A1/fr active
- 1999-04-07 MA MA25527A patent/MA26619A1/fr unknown
- 1999-04-07 MY MYPI99001344A patent/MY133390A/en unknown
- 1999-04-08 ZA ZA9902596A patent/ZA992596B/xx unknown
- 1999-04-08 AP APAP/P/1999/001502A patent/AP1175A/en active
- 1999-04-09 CO CO99021093A patent/CO5080727A1/es unknown
2000
- 2000-09-26 IS IS5641A patent/IS5641A/is unknown
- 2000-10-04 NO NO20005004A patent/NO20005004L/no not_active Application Discontinuation
- 2000-10-06 OA OA1200000273A patent/OA11496A/en unknown
- 2000-11-07 BG BG104915A patent/BG104915A/xx unknown
2003
- 2003-02-11 US US10/364,804 patent/US6887905B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6887905B2 (en)	2005-05-03
SK14782000A3 (sk)	2002-06-04
ES2204154T3 (es)	2004-04-16
AR015751A1 (es)	2001-05-16
TNSN99056A1 (fr)	2005-11-10
OA11496A (en)	2004-05-14
US6525048B1 (en)	2003-02-25
IL138629A0 (en)	2001-10-31
PE20000413A1 (es)	2000-05-25
HRP20000653A2 (en)	2001-04-30
CO5080727A1 (es)	2001-09-25
KR20010042527A (ko)	2001-05-25
KR100378931B1 (ko)	2003-04-07
AP1175A (en)	2003-06-04
TR200002932T2 (tr)	2001-01-22
CA2327782A1 (fr)	1999-10-21
CZ20003684A3 (cs)	2002-03-13
HUP0102400A3 (en)	2002-10-28
DZ2756A1 (fr)	2003-09-15
EA003400B1 (ru)	2003-04-24
PL343408A1 (en)	2001-08-13
CN1305477A (zh)	2001-07-25
MA26619A1 (fr)	2004-12-20
NO20005004D0 (no)	2000-10-04
DE69910997T2 (de)	2004-05-19
AU3268799A (en)	1999-11-01
AP9901502A0 (en)	1999-06-30
BR9909522A (pt)	2000-12-19
PA8469101A1 (es)	2000-09-29
HK1035719A1 (en)	2001-12-07
TW555758B (en)	2003-10-01
MY133390A (en)	2007-11-30
AU749254B2 (en)	2002-06-20
ZA992596B (en)	2000-10-08
JP3496759B2 (ja)	2004-02-16
NZ507010A (en)	2003-05-30
PT1070065E (pt)	2003-12-31
ATE248838T1 (de)	2003-09-15
NO20005004L (no)	2000-11-27
EP1070065B1 (fr)	2003-09-03
US20030181458A1 (en)	2003-09-25
EA200000910A1 (ru)	2001-04-23
WO1999052907A1 (fr)	1999-10-21
DK1070065T3 (da)	2003-11-24
HUP0102400A2 (hu)	2001-11-28
ID26086A (id)	2000-11-23
JP2002511469A (ja)	2002-04-16
EP1070065A1 (fr)	2001-01-24
IS5641A (is)	2000-09-26
CN1117092C (zh)	2003-08-06
DE69910997D1 (de)	2003-10-09
YU59400A (sh)	2003-10-31

Publication	Publication Date	Title
BG104915A (en)	2001-07-31	Azabicyclic 5hti receptor ligands
BG102704A (en)	1999-10-29	Fungicide 2-methoxybenzophenons
BG103485A (en)	2000-01-31	Ketobanzamides as calpain inhibitors
BG105557A (en)	2001-12-29	Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
GB9722520D0 (en)	1997-12-24	Compounds
TR200103273T2 (tr)	2002-04-22	Hemisentetik yöntem ve yeni bileşimler.
CA2341291A1 (fr)	2000-03-23	Pyridinecetones utilises comme herbicides
BG105784A (en)	2002-02-28	Triazole compounds with dopamine-d3-receptor affinity
BG105028A (en)	2001-07-31	Bridged indenopyrrolocarbazoles
BG106340A (en)	2002-10-31	Substituted oxoazaheterocyclyl compounds
BG92804A (bg)	1993-12-24	4-бензоилизоксазолови производни
MY132671A (en)	2007-10-31	Substituted 6,6-hetero-bicyclic derivatives
JO2654B1 (en)	2012-06-17	Multiple aryl caroxa amides are useful as lipid - lowering agents
MX9700430A (es)	1998-05-31	El uso de compuestos heterociclicos.
CY2538B1 (en)	2006-06-28	Tetrahydropyrido compounds
BG105847A (en)	2002-04-30	Calcilytic compounds
CA2356985A1 (fr)	2000-07-06	Antagonistes du recepteur 5ht1 pour therapie antidepressive
MXPA02009549A (es)	2004-05-14	Imidazopiridinas triciclicas.
BG104232A (bg)	2000-10-31	Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
IN187760B (fr)	2002-06-15
BG106002A (en)	2002-06-28	Process for preparing pesticidal intermediates
CA2281702A1 (fr)	1998-08-13	Derives de (4-piperidinyl)-1h-2-benzopyrane convenant comme antipsychotiques
ZA976481B (en)	1998-02-19	Intermediates for the preparation of 2-imidazolin-5-ones.
PL343546A1 (en)	2001-08-27	Processes for preparing intermediates
ZA983231B (en)	1999-10-18	Substituted benzyloxyimino compounds.